← Back
$KRYS All transactions

Krystal Biotech, Inc.

▼ SELL 10b5-1 Plan

$ Value

$976K

Shares

6,500

Price

$150

Filed

Jul 11

Insider

Name

Krishnan Suma

Title

President, R&D

CIK

0001298711

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-07-10

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,457,011

Footnotes

The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person that started on September 12, 2024 and will terminate on September 13, 2025 . | The transaction was executed in multiple trades ranging from $150.1200 to $150.1600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $150.0000 to $150.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in three trades of 100 shares each at $151.350, $151.40, and $151.41, respectively. The price reported above reflects the average sale price. | Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control. | The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish S. Krishnan, that started on September 12, 2024 and will terminate on September 13, 2025. | The transaction was executed in two trades of 100 shares each at $150 and $150.14, respectively. The price reported above reflects the average sale price. | Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.

Filing Info

Accession No.

0001298711-25-000007

Form Type

4

Issuer CIK

0001711279

Krishnan Suma's History

Date Ticker Type Value
2026-03-04 KRYS $105K
2026-03-04 KRYS $152K
2026-03-04 KRYS $173K
2026-03-04 KRYS $955K
2026-03-04 KRYS $766K
2026-03-04 KRYS $508K
2026-03-04 KRYS $593K
2026-03-04 KRYS $1.3M
2026-03-04 KRYS $1.6M
2026-03-04 KRYS $453K

Other Insiders at KRYS (90d)

Insider Bought Sold Last
JANNEY DANIEL $19.4M 2026-02-27
ROSSI DINO A $5.0M 2026-02-19
Krishnan Krish S
President and CEO
$6.6M 2026-03-04
Krishnan Suma
President, R&D
$6.6M 2026-03-04
ROMANO KATHRYN
Chief Accounting Officer
$3.6M 2026-03-02